Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer
Abdalla Awidi(University of Jordan), A.S El-Aloosy(Hamad Medical Corporation), A Jamhoury(Hamad Medical Corporation), A Al Qady(Hamad Medical Corporation), Mary Daniel(Hamad Medical Corporation), S Sulaiti(Hamad Medical Corporation), Anne Felicia Ambrose(Hamad Medical Corporation), Cécile Charles(Université de Bordeaux), Muhammad Kelta(Hamad Medical Corporation), Ussama Al Homsi(Hamad Medical Corporation), Pedro Martínez(Hamad Medical Corporation), R.I Kakail(Hamad Medical Corporation), Arbaz Hassan(Hamad Medical Corporation), Ahmed A. Mubarak(Hamad Medical Corporation)
Cited by 43
Related Papers
siRNA: Mechanism of action, challenges, and therapeutic approaches
|European Journal of Pharmacology|2021|428
Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study
|Journal of Orthopaedic Surgery and Research|2017|141
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy
|CNS Neuroscience & Therapeutics|2017|123